1. Home
  2. EXPO vs HAE Comparison

EXPO vs HAE Comparison

Compare EXPO & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXPO
  • HAE
  • Stock Information
  • Founded
  • EXPO 1967
  • HAE 1971
  • Country
  • EXPO United States
  • HAE United States
  • Employees
  • EXPO N/A
  • HAE N/A
  • Industry
  • EXPO Professional Services
  • HAE Medical/Dental Instruments
  • Sector
  • EXPO Consumer Discretionary
  • HAE Health Care
  • Exchange
  • EXPO Nasdaq
  • HAE Nasdaq
  • Market Cap
  • EXPO 4.1B
  • HAE 3.3B
  • IPO Year
  • EXPO 1990
  • HAE 1991
  • Fundamental
  • Price
  • EXPO $76.34
  • HAE $67.66
  • Analyst Decision
  • EXPO Strong Buy
  • HAE Strong Buy
  • Analyst Count
  • EXPO 1
  • HAE 9
  • Target Price
  • EXPO $120.00
  • HAE $99.78
  • AVG Volume (30 Days)
  • EXPO 299.6K
  • HAE 578.9K
  • Earning Date
  • EXPO 07-24-2025
  • HAE 05-08-2025
  • Dividend Yield
  • EXPO 1.57%
  • HAE N/A
  • EPS Growth
  • EXPO 3.59
  • HAE 44.54
  • EPS
  • EXPO 2.04
  • HAE 3.31
  • Revenue
  • EXPO $518,720,000.00
  • HAE $1,360,824,000.00
  • Revenue This Year
  • EXPO $4.23
  • HAE N/A
  • Revenue Next Year
  • EXPO $7.20
  • HAE $6.76
  • P/E Ratio
  • EXPO $37.42
  • HAE $20.46
  • Revenue Growth
  • EXPO 2.58
  • HAE 3.96
  • 52 Week Low
  • EXPO $73.37
  • HAE $55.30
  • 52 Week High
  • EXPO $115.75
  • HAE $94.99
  • Technical
  • Relative Strength Index (RSI)
  • EXPO 44.02
  • HAE 55.80
  • Support Level
  • EXPO $75.44
  • HAE $65.03
  • Resistance Level
  • EXPO $77.88
  • HAE $68.75
  • Average True Range (ATR)
  • EXPO 1.41
  • HAE 1.40
  • MACD
  • EXPO -0.10
  • HAE -0.24
  • Stochastic Oscillator
  • EXPO 18.40
  • HAE 44.35

About EXPO Exponent Inc.

Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: